Technical Analysis for ORPN - Bio Blast Pharma Ltd.

Grade Last Price % Change Price Change
grade F 1.035 1.47% 0.02
ORPN closed up 1.47 percent on Friday, January 18, 2019, on 6 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical ORPN trend table...

Date Alert Name Type % Chg
Jan 18 20 DMA Support Bullish 0.00%
Jan 18 Doji - Bullish? Reversal 0.00%
Jan 18 Wide Bands Range Expansion 0.00%
Jan 17 20 DMA Support Bullish 1.47%
Jan 17 Doji - Bullish? Reversal 1.47%
Jan 17 Wide Bands Range Expansion 1.47%
Jan 16 50 DMA Resistance Bearish 1.47%
Jan 16 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 1.47%
Jan 16 Outside Day Range Expansion 1.47%
Jan 16 Wide Bands Range Expansion 1.47%

Older signals for ORPN ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Bio Blast Pharma Ltd., a clinical-stage biotechnology company, develops therapies for patients with rare and ultra-rare genetic diseases. Its products include Cabaletta, a mutant protein stabilizing platform based on a small repurposed molecule to treat oculopharyngeal muscular dystrophy, Machado Joseph disease or SCA3, and Kennedy's disease or SBMA; and BBrm, a read-through platform based on a small repurposed molecule that enables the read-through (or bypassing) of genetic defects called nonsense mutations or stop codons that interfere with normal protein formation to treat diseases caused by nonsense mutation. The company's products also comprise mPRT, a mitochondrial protein replacement platform based on biological fusion proteins to treat mitochondrial protein deficiency diseases (Friedrich's Ataxia and ornithine transcarbamylase deficiency) by replacing missing or mutated proteins into mitochondria, and restoring cell function. Bio Blast Pharma Ltd. was founded in 2012 and is headquartered in Tel Aviv, Israel.
Is ORPN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 3.75
52 Week Low 0.77
Average Volume 120,571
200-Day Moving Average 1.5362
50-Day Moving Average 1.1381
20-Day Moving Average 0.962
10-Day Moving Average 1.0225
Average True Range 0.134
ADX 24.77
+DI 19.9712
-DI 10.0629
Chandelier Exit (Long, 3 ATRs ) 0.788
Chandelier Exit (Short, 3 ATRs ) 1.172
Upper Bollinger Band 1.1287
Lower Bollinger Band 0.7953
Percent B (%b) 0.72
BandWidth 34.656965
MACD Line -0.0188
MACD Signal Line -0.0418
MACD Histogram 0.023
Fundamentals Value
Market Cap 3.46 Million
Num Shares 3.34 Million
EPS -3.67
Price-to-Earnings (P/E) Ratio -0.28
Price-to-Sales 0.00
Price-to-Book 1.82
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.19
Resistance 3 (R3) 1.18 1.12 1.16
Resistance 2 (R2) 1.12 1.08 1.12 1.15
Resistance 1 (R1) 1.08 1.06 1.05 1.09 1.14
Pivot Point 1.02 1.02 1.00 1.02 1.02
Support 1 (S1) 0.98 0.98 0.95 0.99 0.93
Support 2 (S2) 0.92 0.96 0.92 0.92
Support 3 (S3) 0.88 0.92 0.91
Support 4 (S4) 0.89